How Phelcom Eyer made Dr. Caio Regatieri’s day to day easier

by Jessyca Beltrami Romero | 29/07/2020 | Company

Doctors’ daily routines, with medical assistance and surgeries in hospitals, as well as care in their own clinics, may be quite distressing. Moreover, other appointments leave these professionals an even tighter schedule. For example, home visits to patients, business management and taking part on congresses, seminars, inter alia.

Therefore, counting on technologies that help improving production, time optimization and cost reduction may largely simplify a doctor’s daily life.

That is why this article is on ophthalmologist Caio Regatieri’s experience with Phelcom Eyer handheld fundus camera. Understand, as follows below, how the equipment made the specialist’s daily life easier.

How does Eyer help Dr. Caio’s routine?

Around a year ago, ophthalmologist Caio Regatieri first met the proposal of a new technology developed by the Brazilian startup Phelcom Technologies: Phelcom Eyer handheld fundus camera. Attached to a smartphone, the equipment generates retina images in few minutes and sends data to a cloud platform.

Thus, it helps diagnose of eye-related diseases, such as diabetic retinopathy, glaucoma, cataract, age-related macular degeneration (AMD), retinoblastoma, retinal detachment, retinopathy of prematurity and blindness, inter alia.

Regatieri has been using the equipment for six months in his office, as well as home visits and in the Brazilian Unified Health System (SUS), in São Paulo Hospital, in the capital.

Since then, the specialist has carried out more than 500 exams, mainly to detect diabetic retinopathy. “Eyer is easy to handle and makes excellent-quality images”, he states.

Retinal examination performed by Dr. Caio with the Phelcom Eyer

Retinal examination performed by Dr. Caio with the Phelcom Eyer

As it provides exams in an online platform, the Eyer Cloud, the doctor also emphasizes the system’s ease of access. “Undoubtedly, having a cloud database makes daily life easier”.

More than that, Regatieri highlights that Eyer has the best cost-effectiveness due to its more accessible price, mainly in comparison to a traditional fundus camera, as well as the high quality. “Actually, it is a set of factors that makes it the best equipment of the market in its sector: portability, image quality, ease of use and the support Phelcom offers”, he says.

Conclusion

Undoubtedly, Phelcom Eyer’s connectivity, embedded artificial intelligence, easy operation, portability and low cost help physicians have a simpler, more agile and profitable routine related to retina exams.

 Phelcom Eyer can help you live an easier daily routine. Click here and register for further information on the technology.

Phelcom presents Eyer at seminar of innovation on health and accessibility

by stuchi | 03/12/2018 | Company

Phelcom Technologies was one of the companies invited to participate in the International Seminar on Innovative Startups in the Area of ​​Health and Inclusion, which took place on November 23 in São Paulo.

The meeting presented the startups business models developed during the Startups Training and Development of People with Disabilities course offered by the São Paulo State Departament for the Rights of Persons with Disabilities in partnership with the University of São Paulo (USP).

In addition to Phelcom, the international companies Renew Senses and Cure Medical were also some of the invited startups.

Phelcom co-founder and CEO José Augusto Stuchi presented the Eyer portable retinal camera, an innovative smartphone device that performs high quality exams. “Portability and low cost compared to the traditional fundus camera democratizes access to retinal examination, helping to prevent and diagnose blindness and severe visual impairment, diseases that affect about 250 million people in the world,” says Stuchi.

Today, 85% of Brazilian cities do not have ophthalmology services. With Eyer, the exams can be done anywhere and the generated data will be automatically synchronized with the internet, allowing the remote diagnosis.

The equipment is expected to be launched in early 2019.